Bioventus (BVS) Non-Current Assets (2020 - 2026)

Bioventus' Non-Current Assets history runs 7 years deep, the most recent figure standing at $400.7 million for Q1 2026.

• Quarterly Non-Current Assets fell 9.35% year-over-year to $400.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 10.0% YoY) and the FY2025 annual result came in at $410.7 million, down 9.2% from the prior year.
• Non-Current Assets was $400.7 million for Q1 2026 at Bioventus, down from $410.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $1.1 billion in Q4 2022 and bottomed at $400.7 million in Q1 2026.
• A 5-year average of $612.4 million and a median of $528.3 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 175.73% — and 2023, when it plunged 50.65%.
• Bioventus' Non-Current Assets stood at $1.1 billion in 2022, then plunged by 50.65% to $542.9 million in 2023, then declined by 16.68% to $452.3 million in 2024, then declined by 9.2% to $410.7 million in 2025, then retreated by 2.43% to $400.7 million in 2026.
• Business Quant data shows BVS's Non-Current Assets at $400.7 million in Q1 2026, $410.7 million in Q4 2025, and $420.7 million in Q3 2025.